MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer

BACKGROUND: No biomarker is available for identifying cancer patients at risk of developing nephrotoxicity when treated with cisplatin. METHODS: We performed microRNA (miRNA) sequencing using plasma collected 5 days after cisplatin treatment (D5) from twelve patients with head and neck cancer with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintanilha, Julia C. F., Cursino, Maria A., Borges, Jessica B., Torso, Nadine G., Bastos, Larissa B., Oliveira, Juliana M., Cobaxo, Thiago S., Pincinato, Eder C., Hirata, Mario H., Geraldo, Murilo V., Lima, Carmen S. P., Moriel, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136168/
https://www.ncbi.nlm.nih.gov/pubmed/34011306
http://dx.doi.org/10.1186/s12885-021-08317-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136168/
https://www.ncbi.nlm.nih.gov/pubmed/34011306
http://dx.doi.org/10.1186/s12885-021-08317-2

Ejemplares similares